Abstract
Objectives Contrary to conventional MRI (cMRI), quantitative MRI (qMRI) quantifies tissue physical microstructural properties and improves the characterization of cerebral damages in relation with various neurological diseases. With a multi-parameter mapping (MPM) protocol, 4 parameter maps are constructed: saturated magnetization transfer (MTsat), proton density (PD), longitudinal relaxation (R1) and effective transverse relaxation (R2*) rates, reflecting tissue physical properties associated with iron and myelin contents. Here, we used qMRI to investigate the microstructural changes happening over time in multiple sclerosis (MS).
Methods Seventeen MS patients (age 25-65, 11 RRMS) were scanned on a 3T MRI, with at least one year separation between two acquisition sessions, and the evolution of their parameters was evaluated within several tissue classes: normal appearing white matter (NAWM), normal appearing cortical and deep gray matter (NACGM and NADGM) as well as focal white matter (WM) lesions. Brain tissue segmentation was performed using US-with-Lesion, an adapted version of the Unified Segmentation (US) algorithm accounting for the lesion tissue class, based on qMRI and FLAIR images. An individual annual rate of change for each qMRI parameter was computed, and its correlation to clinical status was evaluated. As for WM plaques, three areas were defined within them. A Generalized Linear Mixed Model (GLMM) tested the effect of area and time points, as well as their interaction on each median qMRI parameter value.
Results Patients with a better clinical evolution showed positive annual rate of change in MT and R2* within NAWM and NACGM, suggesting repair mechanisms in terms of increased myelin content and/or axonal density. When examining focal WM lesions, qMRI parameters within surrounding NAWM showed modification in terms of reduction in MT, R1 and R2* combined with increased of PD even before any focal lesion is visible on conventional FLAIR MRI.
Conclusion The results illustrate the benefit of multiple qMRI data in monitoring subtle changes within normal appearing brain tissues and plaque dynamics in relation with tissue repair or disease progression.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The main contributors are supported by the Fonds de la Recherche Scientifique (F.R.S-FNRS Belgium)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the University of Liege Hospital gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Abbreviations: ARoC: Annual Rate of Change, BPF: Brain Parenchymal Fraction, CDP: Confirmed Disability Progression, cMRI: Conventional Magnetic Resonance Imaging, CNS: Central Nervous System, GMF: Grey Matter Fraction, GLMM: General Linear Mixed Model, LF: Lesion Fraction, MPM: Multiparameter mapping, MRI: Magnetic Resonance Imaging, MS: Multiple Sclerosis, MT: Magnetization Transfer, MTR: Magnetization Transfer Ratio, MTsat: Saturated Magnetization Transfer, NABT: Normal Appearing Brain Tissue, NACGM: Normal Appearing Cortical Grey Matter, NADGM: Normal Appearing Deep Grey matter, NAWM: Normal Appearing White Matter, NEDA-3: No Evidence of Disease Activity, RRMS: Relapsing-Remitting Multiple Sclerosis, PD: Proton Density, PMS: Progressive Multiple Sclerosis, qMRI: Quantitative Magnetic Resonance Imaging, R1: Longitudinal Relaxation Rate (1/T1), R2*: Transverse Relaxation Rate (1/T2*), TIV: Total Intracranial Volume, TPM: Tissue Probability Map, US: Unified Segmentation, USwL: Unified Segmentation with Lesion
Data Availability
All data produced in the present study are available upon reasonable request to the authors
